Heparin and LMW heparin: Dosing and adverse effects
This topic will review the general principles underlying the therapeutic use of unfractionated and LMW heparins including dosing, monitoring, and reversal of
Low-molecular-weight heparin
Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. [1] They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein
LMWH, Anticoagulation Clinic | UC San Diego Health
Low molecular weight heparin (LMWH) is a class of medication used as an anticoagulant in diseases that feature thrombosis, as well as for prophylaxis in situations that lead to a high risk
Low Molecular Weight Heparin (LMWH)
Low molecular weight heparin (LMWH) is derived from unfractionated heparin (UFH) by digestion or depolymerization of longer chains of heparin into shorter chains by chemical or enzymatic
Low Molecular Weight Heparin
Routine monitoring of Anti-Xa levels is not recommended as there is no “therapeutic range” for LMWH. For more specific guidance see Monitoring of Antithrombotic Therapy.
Low Molecular Weight Heparin: Drug Class, Uses, Side Effects
Low molecular weight heparin is an anticoagulant drug used for removing blood clots. Learn about how they work, usages, side effects, and a list of drugs.
Anticoagulation
LMWH is generally preferable in the ICU because it has a shorter duration of action (half-life of ~4 hours versus ~20 hours). Therapeutic fondaparinux is problematic if the patient